L
Li Bang International Corporation Inc
NASDAQ:LBGJ
Li Bang International Corporation Inc
NASDAQ:LBGJ
Price:
0.9329
USD
8 957.28%
Market Closed
Market Cap:
$17.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
L
|
Li Bang International Corporation Inc
NASDAQ:LBGJ
|
CN |
|
Marker Therapeutics Inc
NASDAQ:MRKR
|
US |
|
J
|
JLK Inc
KOSDAQ:322510
|
KR |
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
IN |
|
Al Masane Al Kobra Mining Company CJSC
SAU:1322
|
SA |
|
Moonpig Group PLC
LSE:MOON
|
UK |
|
S
|
Sunwels Co Ltd
TSE:9229
|
JP |
|
Enzon Pharmaceuticals Inc
OTC:ENZN
|
US |
|
Qudian Inc
NYSE:QD
|
CN |
Balance Sheet
Balance Sheet Decomposition
Li Bang International Corporation Inc
Li Bang International Corporation Inc
Balance Sheet Decomposition is not available for
Li Bang International Corporation Inc
Li Bang International Corporation Inc
Balance Sheet
Li Bang International Corporation Inc
Li Bang International Corporation Inc
Currency: USD
| Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
1
|
|
| Cash |
0
|
0
|
0
|
0
|
1
|
|
| Total Receivables |
6
|
9
|
12
|
12
|
13
|
|
| Accounts Receivables |
5
|
9
|
12
|
12
|
12
|
|
| Other Receivables |
1
|
0
|
0
|
0
|
1
|
|
| Inventory |
4
|
2
|
2
|
2
|
2
|
|
| Other Current Assets |
0
|
1
|
2
|
1
|
4
|
|
| Total Current Assets |
11
|
12
|
15
|
16
|
20
|
|
| PP&E Net |
4
|
4
|
3
|
3
|
3
|
|
| PP&E Gross |
4
|
4
|
3
|
3
|
3
|
|
| Accumulated Depreciation |
3
|
3
|
4
|
4
|
4
|
|
| Intangible Assets |
1
|
1
|
1
|
1
|
1
|
|
| Note Receivable |
1
|
2
|
1
|
1
|
4
|
|
| Long-Term Investments |
0
|
0
|
3
|
3
|
0
|
|
| Other Long-Term Assets |
0
|
2
|
2
|
3
|
1
|
|
| Total Assets |
17
N/A
|
20
+21%
|
25
+24%
|
25
-1%
|
28
+11%
|
|
| Liabilities | ||||||
| Accounts Payable |
3
|
4
|
4
|
5
|
4
|
|
| Accrued Liabilities |
0
|
1
|
1
|
1
|
1
|
|
| Short-Term Debt |
4
|
7
|
10
|
7
|
8
|
|
| Other Current Liabilities |
5
|
4
|
5
|
5
|
4
|
|
| Total Current Liabilities |
11
|
15
|
20
|
17
|
17
|
|
| Long-Term Debt |
0
|
0
|
0
|
4
|
3
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
11
N/A
|
15
+34%
|
20
+32%
|
21
+5%
|
20
-4%
|
|
| Equity | ||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
3
|
3
|
4
|
2
|
1
|
|
| Additional Paid In Capital |
2
|
2
|
2
|
2
|
7
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
6
N/A
|
5
-5%
|
6
+4%
|
4
-23%
|
8
+82%
|
|
| Total Liabilities & Equity |
17
N/A
|
20
+21%
|
25
+24%
|
25
-1%
|
28
+11%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
19
|
19
|
19
|
17
|
19
|
|
Switch to:
Switch to:
See Also
Discover More
